Social Anxiety Disorder in Genuine Halitosis Patients

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2011 Nov 5

PMID 22051118

Citations 18

Authors

Takashi Zaitsu

Masayuki Ueno

Kayoko Shinada

Fredrick A Wright

Yoko Kawaguchi

Affiliations

Soon will be listed here.

Abstract

Background: There is a possibility that genuine halitosis patients' anxiety do not recover after oral malodor treatment due to their social anxiety disorder. The objective of this study was to investigate the influence of social anxiety disorder on the level of anxiety in genuine halitosis patients before and after treatment for oral malodor.

Methods: The subjects were 262 genuine halitosis patients who visited the Fresh Breath Clinic from March, 2008 to October, 2009. The subjects who had score 2 or higher by the organoleptic test were diagnosed as genuine halitosis patients. Gas chromatography (GC) was conducted before and after oral malodor treatment for the oral malodor measurement. Based on their risk of social anxiety disorder, subjects were divided into low- and high-risk groups using the Liebowitz Social Anxiety Scale (LSAS). The questions related to oral malodor and the clinical oral examination were both conducted before oral malodor treatment. The level of anxiety before and after oral malodor treatment was evaluated using the Visual Analogue Scale of Anxiety (VAAS).

Results: More than 20% of subjects had a score of 60 or more on the LSAS (high LSAS group). The mean age and the percentage of females were significantly higher in the high LSAS group compared to the low LSAS group. The high LSAS group was more likely to have problems associated with oral malodor and to adopt measures against oral malodor compared to the low LSAS group. The mean concentrations of H2S and CH3SH by GC significantly decreased after the oral malodor treatment in both LSAS groups. VAAS scores also significantly decreased after treatment in both LSAS groups. The logistic regression analysis indicated that the high LSAS group had a 2.28 times higher risk of having a post-VAAS score of 50 or more compared to the low LSAS group.

Conclusions: This study revealed that genuine halitosis patients with a strong trait of social anxiety disorder have difficulty overcoming their anxiety about oral malodor. Oral malodor treatment of genuine halitosis patients requires not only regular oral malodor treatment but also attention to social anxiety disorder.

Citing Articles

Halitosis in young patients with chronic kidney disease: findings from a randomized controlled trial.

Hoefer K, Barbe A, Adams A, Schoppmeier C, Wicht M, Weber L Head Face Med. 2024; 20(1):32.

PMID: 38750491 PMC: 11094915. DOI: 10.1186/s13005-024-00428-y.

Association of oral health with various work problems: a cross-sectional study of Japanese workers.

Shimada S, Zaitsu T, Oshiro A, Kino S, Aida J BMC Oral Health. 2023; 23(1):488.

PMID: 37454055 PMC: 10349489. DOI: 10.1186/s12903-023-03196-4.

Clinical Trial Evaluating Quality of Life in Patients with Intra-Oral Halitosis.

Olszewska-Czyz I, Sozkes S, Dudzik A J Clin Med. 2022; 11(2).

PMID: 35054019 PMC: 8779688. DOI: 10.3390/jcm11020326.

Neurodevelopmental Disorder Traits in and Social Anxiety Disorder: A Cross-Sectional Study among University Students.

Kajitani K, Tsuchimoto R, Omodaka Y, Matsushita T, Fukumori H, Sato T Psychiatry J. 2021; 2021:1661617.

PMID: 34568483 PMC: 8463244. DOI: 10.1155/2021/1661617.

Association of periodontitis with oral malodor in Korean adults.

Song Y, Ahn Y, Shin M, Brennan D, Kim H PLoS One. 2021; 16(3):e0247947.

PMID: 33661974 PMC: 7932065. DOI: 10.1371/journal.pone.0247947.

References

Bez Y, Coskun E, Erol K, Cingu A, Eren Z, Topcuoglu V . Adult strabismus and social phobia: a case-controlled study. J AAPOS. 2009; 13(3):249-52. DOI: 10.1016/j.jaapos.2009.02.010. View

Gift A . Visual analogue scales: measurement of subjective phenomena. Nurs Res. 1989; 38(5):286-8. View

Rosenberg M, Kozlovsky A, Wind Y, Mindel E . Self-assessment of oral malodor 1 year following initial consultation. Quintessence Int. 2000; 30(5):324-7. View

Kessler R . The impairments caused by social phobia in the general population: implications for intervention. Acta Psychiatr Scand Suppl. 2003; (417):19-27. DOI: 10.1034/j.1600-0447.108.s417.2.x. View

Ballenger J, Davidson J, Lecrubier Y, Nutt D, Bobes J, Beidel D . Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 17:54-60. View

Rosenberg M, Kulkarni G, Bosy A, McCulloch C . Reproducibility and sensitivity of oral malodor measurements with a portable sulphide monitor. J Dent Res. 1991; 70(11):1436-40. DOI: 10.1177/00220345910700110801. View

Sopapornamorn P, Ueno M, Shinada K, Vachirarojpisan T, Kawaguchi Y . Clinical application of a VSCs monitor for oral malodour assessment. Oral Health Prev Dent. 2006; 4(2):91-7. View

Mannuzza S, Schneier F, Chapman T, Liebowitz M, Klein D, Fyer A . Generalized social phobia. Reliability and validity. Arch Gen Psychiatry. 1995; 52(3):230-7. DOI: 10.1001/archpsyc.1995.03950150062011. View

Weinshenker N, Goldenberg I, ROGERS M, Goisman R, Warshaw M, Fierman E . Profile of a large sample of patients with social phobia: comparison between generalized and specific social phobia. Depress Anxiety. 1996; 4(5):209-16. DOI: 10.1002/(SICI)1520-6394(1996)4:5<209::AID-DA1>3.0.CO;2-8. View

10.

Heimberg R . Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Biol Psychiatry. 2002; 51(1):101-8. DOI: 10.1016/s0006-3223(01)01183-0. View

11.

Coil J, Yaegaki K, Matsuo T, Miyazaki H . Treatment needs (TN) and practical remedies for halitosis. Int Dent J. 2002; 52 Suppl 3:187-91. DOI: 10.1002/j.1875-595x.2002.tb00922.x. View

12.

Rosenberg M, McCulloch C . Measurement of oral malodor: current methods and future prospects. J Periodontol. 1992; 63(9):776-82. DOI: 10.1902/jop.1992.63.9.776. View

13.

Yao S, Note I, Fanget F, Albuisson E, Bouvard M, Jalenques I . [Social anxiety in patients with social phobia: validation of the Liebowitz social anxiety scale: the French version]. Encephale. 1999; 25(5):429-35. View

14.

Fedoroff I, Taylor S . Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol. 2001; 21(3):311-24. DOI: 10.1097/00004714-200106000-00011. View

15.

Yaegaki K, Coil J . Examination, classification, and treatment of halitosis; clinical perspectives. J Can Dent Assoc. 2000; 66(5):257-61. View

16.

Rosenberg M, Septon I, Eli I, Gelernter I, Brenner S, Gabbay J . Halitosis measurement by an industrial sulphide monitor. J Periodontol. 1991; 62(8):487-9. DOI: 10.1902/jop.1991.62.8.487. View

17.

Liebowitz M, Heimberg R, Schneier F, Hope D, Davies S, HOLT C . Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety. 1999; 10(3):89-98. View

18.

TONZETICH J . Production and origin of oral malodor: a review of mechanisms and methods of analysis. J Periodontol. 1977; 48(1):13-20. DOI: 10.1902/jop.1977.48.1.13. View

19.

Oho T, Yoshida Y, Shimazaki Y, Yamashita Y, Koga T . Psychological condition of patients complaining of halitosis. J Dent. 2001; 29(1):31-3. DOI: 10.1016/s0300-5712(00)00057-9. View

20.

Mennin D, Fresco D, Heimberg R, Schneier F, Davies S, Liebowitz M . Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord. 2002; 16(6):661-73. DOI: 10.1016/s0887-6185(02)00134-2. View